Company
Headquarters: New Taipei City, Taiwan
CEO: Gene Chen
TW$2.39 Billion
TWD as of July 1, 2025
US$81.5 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $222.61 B |
| Danaher | $164.98 B |
| Siemens Healthineers AG | $57.84 B |
| IDEXX Laboratories, Inc. | $53.62 B |
| Lonza Group Ltd | $47.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. It provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays; and displays to ODM and OEM customers. The company is headquartered in New Taipei City, Taiwan.
DIVA Laboratories Ltd has the following listings and related stock indices.
Stock: TWSE: 4153 wb_incandescent